163 related articles for article (PubMed ID: 20379094)
1. [A case of sacroiliitis complicated with ulcerative colitis which was treated with leukocytapheresis].
Norimura D; Mizuta Y; Isomoto H; Yamaguchi N; Ohnita K; Shikuwa S; Takeshima F; Nakao K
Nihon Shokakibyo Gakkai Zasshi; 2010 Apr; 107(4):605-11. PubMed ID: 20379094
[TBL] [Abstract][Full Text] [Related]
2. [A case of sacroiliitis complicated by ulcerative colitis that was successfully treated with steroid].
Kubota D; Kanai T; Matsumoto T; Kawamura T; Itsui Y; Okada E; Chin S; Ohoka S; Tsuchiya K; Araki A; Sakamoto N; Miyata T; Watanabe M
Nihon Shokakibyo Gakkai Zasshi; 2006 Aug; 103(8):936-42. PubMed ID: 16912460
[TBL] [Abstract][Full Text] [Related]
3. A case report: first case of filtration leukocytapheresis for a patient of aortitis syndrome associated with ulcerative colitis.
Fukunaga K; Sawada K; Fukuda Y; Matoba Y; Onishi K; Fukui S; Yamamura M; Satomi M; Shimoyama T
Ther Apher; 2002 Feb; 6(1):93-8. PubMed ID: 11886584
[TBL] [Abstract][Full Text] [Related]
4. Influence of leukocytapheresis therapy for ulcerative colitis on anemia and hemodynamics.
Miyamoto H; Okahisa T; Iwaki H; Murata M; Ito S; Nitta Y; Akutagawa M; Kinouchi Y; Ohnishi Y; Oto J; Nishimura M
Ther Apher Dial; 2007 Feb; 11(1):16-21. PubMed ID: 17309570
[TBL] [Abstract][Full Text] [Related]
5. [A case of ulcerative colitis with hematuria and renal dysfunction after leukocytapheresis].
Makino K; Masutani M; Sato S; Hamamoto H
Nihon Shokakibyo Gakkai Zasshi; 2006 Oct; 103(10):1134-8. PubMed ID: 17023755
[TBL] [Abstract][Full Text] [Related]
6. A multicenter, retrospective, observational study of the clinical outcomes and risk factors for relapse of ulcerative colitis at 1 year after leukocytapheresis.
Kobayashi T; Matsuoka K; Yokoyama Y; Nakamura T; Ino T; Numata T; Shibata H; Aoki H; Matsuno Y; Hibi T
J Gastroenterol; 2018 Mar; 53(3):387-396. PubMed ID: 28597225
[TBL] [Abstract][Full Text] [Related]
7. Relationship between ulcerative colitis patients treated with leukocytapheresis and ulcerative colitis-associated colorectal cancer.
Kinugasa T; Akagi Y; Murotani K; Romeo K; Yoshida T; Ryu Y; Shiratuchi I; Shirouzu K
Anticancer Res; 2011 Jul; 31(7):2547-52. PubMed ID: 21873173
[TBL] [Abstract][Full Text] [Related]
8. [Arthritic manifestations in ulcerative colitis].
Momohara S
Nihon Rinsho; 1999 Nov; 57(11):2566-70. PubMed ID: 10572432
[TBL] [Abstract][Full Text] [Related]
9. Leukocytapheresis (LCAP) for management of fulminant ulcerative colitis with toxic megacolon.
Sawada K; Egashira A; Ohnishi K; Fukunaga K; Kusaka T; Shimoyama T
Dig Dis Sci; 2005 Apr; 50(4):767-73. PubMed ID: 15844716
[TBL] [Abstract][Full Text] [Related]
10. Ulcerative colitis complicating seronegative HLA-A2-B27 rheumatoid arthritis with sacroiliitis.
Klausen T; Amris K; Helin P
Ann Rheum Dis; 1992 Aug; 51(8):1009-11. PubMed ID: 1417108
[TBL] [Abstract][Full Text] [Related]
11. [A case of tacrolimus plus intensive LCAP therapy combination for refractory ulcerative colitis].
Matsumoto A; Yajima H; Murata T; Gotou K; Okamoto K; Nishiyama H
Nihon Shokakibyo Gakkai Zasshi; 2013 Apr; 110(4):639-47. PubMed ID: 23558127
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of leukocytapheresis in suppressing the occurrence of surgical site infections following surgery for ulcerative colitis.
Itabashi M; Ikeuchi H; Araki T; Kono T; Nakamura T; Takesue Y; Kameoka S; Kusunoki M
Surg Today; 2008; 38(7):609-17. PubMed ID: 18612785
[TBL] [Abstract][Full Text] [Related]
13. Development of ulcerative colitis during the course of rheumatoid arthritis: Association with selective IgA deficiency.
Asada Y; Isomoto H; Shikuwa S; Wen CY; Fukuda E; Miyazato M; Okamoto K; Nakamura T; Nishiyama H; Mizuta Y; Migita K; Ito M; Kohno S
World J Gastroenterol; 2006 Aug; 12(32):5240-3. PubMed ID: 16937542
[TBL] [Abstract][Full Text] [Related]
14. [Remission by leukocytapheresis for a patient with ulcerative colitis found refractory by conventional drug therapies].
Sawada K; Ohnishi K; Kosaka T; Egashira A; Kinoshita T; Amano K; Yamamura M; Satomi M; Shimoyama T
Nihon Rinsho Meneki Gakkai Kaishi; 1997 Apr; 20(2):126-33. PubMed ID: 9178970
[TBL] [Abstract][Full Text] [Related]
15. Extraintestinal manifestations of idiopathic ulcerative colitis.
Kochhar R; Mehta SK; Nagi B; Bhatia V; Goenka MK; Malik AK
Indian J Gastroenterol; 1991 Jul; 10(3):88-9. PubMed ID: 1916969
[TBL] [Abstract][Full Text] [Related]
16. Univariate analysis to examine predictors of response to leukocytapheresis in ulcerative colitis patients.
Nagayama K; Takedatsu H; Mitsuyama K; Yamasaki H; Kuwaki K; Yoshioka S; Kobayashi T; Yamauchi R; Kakuma T; Sata M
Ther Apher Dial; 2014 Jun; 18(3):244-51. PubMed ID: 24965290
[TBL] [Abstract][Full Text] [Related]
17. LEUKOCYTAPHERESIS IN THE MANAGEMENT OF SEVERE STEROID-DEPENDENT ULCERATIVE COLITIS.
Krznarić Ž; Markoš P; Golubić Ćepulić B; Čuković-Čavka S; Domislović V; Bojanić I; Barišić A; Kekez D
Acta Clin Croat; 2019 Sep; 58(3):529-534. PubMed ID: 31969767
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors of response to leukocytapheresis therapy for ulcerative colitis.
Yajima T; Takaishi H; Kanai T; Iwao Y; Watanabe M; Ishii H; Hibi T
Ther Apher; 1998 May; 2(2):115-9. PubMed ID: 10225711
[TBL] [Abstract][Full Text] [Related]
19. Leukocytapheresis (LCAP) in the management of chronic active ulcerative colitis--results of a randomized pilot trial.
Emmrich J; Petermann S; Nowak D; Beutner I; Brock P; Klingel R; Mausfeld-Lafdhiya P; Liebe S; Ramlow W
Dig Dis Sci; 2007 Sep; 52(9):2044-53. PubMed ID: 17410456
[TBL] [Abstract][Full Text] [Related]
20. Leukocytapheresis therapy for severe ulcerative colitis.
Sasaki M; Tsujikawa T; Fujiyama Y; Bamba T
Ther Apher; 1998 May; 2(2):101-4. PubMed ID: 10225708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
